Skip to content

Abaloparatide (Tymlos) studies: 157 papers with results

Page 2 of 4

  1. An Evaluation of Treatment Patterns for Osteoporosis and Outcomes After a Fragility Fracture in a Real-World Setting.

    Singer AJ · Journal of orthopaedic trauma · 2023

    Observational study · 2 results

  2. A real-world pharmacovigilance study of abaloparatide based on the FDA Adverse Event Reporting System (FAERS).

    Shi X · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023

    Observational study · 10 results

  3. Cardiovascular Safety Signals of Osteoporosis Therapies: A FAERS Pharmacovigilance Study.

    Sondhi M · Mediterranean journal of rheumatology · 2026

    Observational study · 1 result

  4. Association of Osteoporosis and Bone-Strengthening Medications with Postoperative Outcomes Following Transforaminal Lumbar Interbody Fusion.

    Khalid SI · World neurosurgery · 2025

    Observational study · 1 result

  5. The use of abaloparatide to treat nonunion following dorsal closing wedge osteotomy for Freiberg's disease: A case report.

    Nelson JA · Bone reports · 2021

    Case report or series · 2 results

  6. Skeletal fluorosis: an uncommon cause, yet a rescue treatment?

    Shariff JRR · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024

    Case report or series · 2 results

  7. An Overlooked Medication-Induced Celiac Flare Complicating Treatment of Osteoporosis.

    Phan V · AACE clinical case reports · 2024

    Case report or series · 1 result

  8. New Human Leukocyte Antigen (HLA) Antibody Formation and Creatinine Elevation With Abaloparatide in Kidney Transplant Recipient.

    Swanson CM · JBMR plus · 2023

    Case report or series · 6 results

  9. Biological activation of prolonged delayed fracture healing following abaloparatide under stable circular external fixation: successful limb salvage of a Gustilo type III-C pilon fracture in severe immune thrombocytopenia-a case report.

    Nozaka K · Journal of medical case reports · 2026

    Case report or series · 4 results

  10. Rapid fracture healing of the greater tuberosity fragment after shoulder hemiarthroplasty in a patient with daily abaloparatide injection: A case report.

    Joko I · Bone reports · 2026

    Case report or series · 2 results

  11. MON-365 Novel Use of Abaloparatide to Augment Spinal Fusion in Patient Undergoing Cervicothoracic Revision Surgery

    Parikh S · Journal of the Endocrine Society · 2020

    Case report or series · 1 result

  12. SUN-335 Abaloparatide Prevents Unloading-Induced Bone Loss in Adult Rats

    Teguh D · Journal of the Endocrine Society · 2020

    Animal study (in vivo) · rat · 11 results

  13. Anti-sclerostin antibodies and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female rats.

    Brent MB · Bone · 2022

    Animal study (in vivo) · rat · 7 results

  14. Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption.

    Chandler H · Bone · 2019

    Animal study (in vivo) · rat · 8 results

  15. Abaloparatide improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male osteoporosis.

    Besschetnova T · Bone · 2019

    Animal study (in vivo) · rat · 13 results

  16. Preoperative abaloparatide plus zoledronate treatment accelerates femoral bone healing in rats following osteotomy.

    Kataoka T · Journal of orthopaedic surgery (Hong Kong) · 2024

    Animal study (in vivo) · rat · 18 results

  17. Teriparatide and Abaloparatide Have a Similar Effect on Bone in Mice.

    Brent MB · Frontiers in endocrinology · 2021

    Animal study (in vivo) · mouse · 16 results

  18. Abaloparatide Enhances Fusion and Bone Formation in a Rabbit Spinal Arthrodesis Model.

    Morse KW · Spine · 2022

    Animal study (in vivo) · rabbit · 12 results

  19. Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia.

    Chandler H · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2019

    Animal study (in vivo) · rabbit · 10 results

  20. The Effect of Abaloparatide on New Bone Formation in Critical Calvarial Defectsin a Postmenopausal Model.

    Özdoğan Z · The Journal of craniofacial surgery · 2025

    Animal study (in vivo) · rat · 16 results

  21. Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1-34).

    Jolette J · Regulatory toxicology and pharmacology : RTP · 2017

    Animal study (in vivo) · rat · 13 results

  22. Parathyroid hormone(1-34) and its analogs differentially modulate osteoblastic Rankl expression via PKA/SIK2/SIK3 and PP1/PP2A-CRTC3 signaling.

    Ricarte FR · The Journal of biological chemistry · 2018

    Animal study (in vivo) · 22 results

  23. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.

    Doyle N · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018

    Animal study (in vivo) · cynomolgus monkey · 16 results

  24. One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.

    Varela A · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017

    Animal study (in vivo) · rat · 16 results

  25. Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats.

    Bahar H · Calcified tissue international · 2016

    Animal study (in vivo) · rat · 18 results

  26. Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β-arrestin recruitment than teriparatide.

    Sahbani K · Physiological reports · 2019

    Animal study (in vivo) · mouse · 25 results

  27. Abaloparatide Exerts Bone Anabolic Effects with Less Stimulation of Bone Resorption-Related Factors: A Comparison with Teriparatide.

    Makino A · Calcified tissue international · 2018

    Animal study (in vivo) · rat · 24 results

  28. One year of abaloparatide, a selective peptide activator of the PTH1 receptor, increased bone mass and strength in ovariectomized rats.

    Varela A · Bone · 2017

    Animal study (in vivo) · rat · 15 results

  29. Abaloparatide at the Same Dose Has the Same Effects on Bone as PTH (1-34) in Mice.

    Le Henaff C · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020

    Animal study (in vivo) · mouse · 20 results

  30. Abaloparatide Improves Rotator Cuff Healing via Anabolic Effects on Bone Remodeling in a Chronic Rotator Cuff Tear Model of Rat With Osteoporosis: A Comparison With Denosumab.

    Xu J · The American journal of sports medicine · 2022

    Animal study (in vivo) · rat · 9 results

  31. Abaloparatide versus teriparatide: a head to head comparison of effects on fracture healing in mouse models.

    Bernhardsson M · Acta orthopaedica · 2018

    Animal study (in vivo) · mouse · 8 results

  32. Activation of PTH1R alleviates epididymitis and orchitis through Gq and β-arrestin-1 pathways.

    Wang MW · Proceedings of the National Academy of Sciences of the United States of America · 2021

    Animal study (in vivo) · mouse · 5 results

  33. Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice.

    Arlt H · Bone reports · 2020

    Animal study (in vivo) · mouse · 24 results

  34. Abaloparatide, a PTH receptor agonist with homology to PTHrP, enhances callus bridging and biomechanical properties in rats with femoral fracture.

    Lanske B · Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2019

    Animal study (in vivo) · rat · 10 results

  35. Frequent administration of abaloparatide shows greater gains in bone anabolic window and bone mineral density in mice: A comparison with teriparatide.

    Makino A · Bone · 2021

    Animal study (in vivo) · mouse · 16 results

  36. Effects of systemically administered abaloparatide, an osteoanabolic PTHrP analog, as an adjuvant therapy for spinal fusion in rats.

    Arlt H · JOR spine · 2021

    Animal study (in vivo) · rat · 6 results

  37. Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice.

    Brent MB · Scientific reports · 2021

    Animal study (in vivo) · mouse · 10 results

  38. The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar.

    Brent MB · Frontiers in endocrinology · 2020

    Animal study (in vivo) · rat · 14 results

  39. Abaloparatide outperforms teriparatide in protecting against alveolar bone loss in experimental periodontitis.

    Li Y · Journal of periodontology · 2023

    Animal study (in vivo) · rat · 14 results

  40. Comparative study in estrogen-depleted mice identifies skeletal and osteocyte transcriptomic responses to abaloparatide and teriparatide.

    Lv Z · JCI insight · 2023

    Animal study (in vivo) · mouse · 9 results

  41. Abaloparatide treatment increases bone formation, bone density and bone strength without increasing bone resorption in a rat model of hindlimb unloading.

    Teguh DA · Bone · 2021

    Animal study (in vivo) · rat · 15 results

  42. Abaloparatide promotes bone repair of vertebral defects in ovariectomized rats by increasing bone formation.

    Makino A · Bone · 2024

    Animal study (in vivo) · rat · 8 results

  43. Abaloparatide Enhances Bone Regeneration in Extraction Socket Dental Implant Defects: An Experimental In Vivo Study.

    Latimer J · Clinical oral implants research · 2025

    Animal study (in vivo) · rat · 5 results

  44. Healing sequelae following tooth extraction and dental implant placement in an aged, ovariectomy model.

    Latimer JM · JBMR plus · 2024

    Animal study (in vivo) · rat · 6 results

  45. Abaloparatide is more potent than teriparatide in restoring bone mass and strength in type 1 diabetic male mice.

    Marino S · Bone · 2024

    Animal study (in vivo) · mouse · 23 results

  46. Local abaloparatide administration promotes in situ alveolar bone augmentation via FAK-mediated periosteal osteogenesis.

    Wang R · International journal of oral science · 2025

    Animal study (in vivo) · 11 results

  47. Abaloparatide increases bone mass without affecting growth of bone-disseminated cancer cells.

    Kane JF · JBMR plus · 2025

    Animal study (in vivo) · mouse · 4 results

  48. Abaloparatide Maintains Normal Rat Blood Calcium Level in Part Via 1,25-Dihydroxyvitamin D/osteocalcin Signaling Pathway.

    Yang Y · Endocrinology · 2023

    Animal study (in vivo) · rat · 9 results

  49. Abaloparatide prevents immobilization-induced cortical but not trabecular bone loss after spinal cord injury.

    Sahbani K · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023

    Animal study (in vivo) · mouse · 10 results

  50. Abaloparatide and teriparatide enhance mandibular growth in adolescent rats with site-specific and mechano-related effects.

    Wang R · European journal of orthodontics · 2023

    Animal study (in vivo) · rat · 34 results

How PepBank reports evidence